We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$9.15M
Cap. Flow
-$18.1M
Cap. Flow %
-12.5%
Top 10 Hldgs %
26.79%
Holding
704
New
1
Increased
73
Reduced
49
Closed
564

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$269K
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$197K
3
MO icon
Altria Group
MO
+$144K
4
MPT
Medical Properties Trust
MPT
+$127K
5
XOM icon
ExxonMobil
XOM
+$117K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$582K
2
MPC icon
Marathon Petroleum
MPC
+$200K
3
AER icon
AerCap
AER
+$196K
4
XPO icon
XPO
XPO
+$195K
5
CPB icon
Campbell Soup
CPB
+$186K

Sector Composition

Rank Sector Weight
1 Technology 16.31%
2 Healthcare 10.05%
3 Consumer Staples 8.95%
4 Communication Services 7.78%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLE icon
601
State Street Energy Select Sector SPDR ETF
XLE
$37.6B
– –
-1,600
Closed -$47K
XLF icon
602
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
– –
-1,000
Closed -$28K
XLG icon
603
Invesco S&P 500 Top 50 ETF
XLG
$11B
– –
-450
Closed -$10K
XLI icon
604
State Street Industrial Select Sector SPDR ETF
XLI
$34.6B
– –
-313
Closed -$24K
XLK icon
605
State Street Technology Select Sector SPDR ETF
XLK
$123B
– –
-900
Closed -$36K
XLP icon
606
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
– –
-166
Closed -$10K
XLRE icon
607
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.65B
– –
-1,233
Closed -$49K
XLV icon
608
State Street Health Care Select Sector SPDR ETF
XLV
$43.3B
– –
-50
Closed -$5K
XNTK icon
609
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
– –
-30
Closed -$2K
XOMA
610
DELISTED
Xoma
XOMA
– –
-403
Closed -$8K
XPO icon
611
XPO
XPO
$23.7B
– –
-7,894
Closed -$195K
XRX icon
612
Xerox
XRX
$425M
– –
-607
Closed -$18K
XXII
613
22nd Century Group
XXII
$1.48M
– –
0
– -$3K
YOLO icon
614
AdvisorShares Pure Cannabis ETF
YOLO
$31.1M
– –
-203
Closed -$3K
YUM icon
615
Yum! Brands
YUM
$41.1B
– –
-120
Closed -$14K
YUMC icon
616
Yum China
YUMC
$16.3B
– –
-120
Closed -$5K
ZD icon
617
Ziff Davis
ZD
$1.98B
– –
-462
Closed -$37K
ZTS icon
618
Zoetis
ZTS
$30B
– –
-176
Closed -$22K
ZYME icon
619
Zymeworks
ZYME
$1.67B
– –
-1,000
Closed -$25K
ARQ icon
620
Arq
ARQ
$89.3M
– –
-300
Closed -$4K
CSCI
621
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
– –
-38
Closed -$4K
FLG
622
Flagstar Bank National Association
FLG
$5.82B
– –
-446
Closed -$17K
GRCE
623
Grace Therapeutics
GRCE
$34.7M
– –
-25
Closed -$2K
MTVA
624
MetaVia Inc
MTVA
$7.69M
– –
0
– -$2K
PVLA
625
Palvella Therapeutics
PVLA
$2.27B
– –
-16
Closed -$4K
23 24
25
26 27

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Truvestments Capital held 704 positions worth $144M, down 6% from $154M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Truvestments Capital withdrew a net $18.1M in Q4 2019, closing 564 positions and reducing 49 holdings. Its most notable exit was Celgene Corp, an estimated $582K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Truvestments Capital opened a new position in Vanguard FTSE Developed Markets ETF worth $204K.

  • Truvestments Capital's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 4,627 shares worth $204K.
  • Truvestments Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $269K increase.
  • Truvestments Capital's biggest Q4 2019 reduction was Apple, cutting an estimated $151K.
  • Truvestments Capital fully exited Celgene Corp in Q4 2019, selling an estimated $582K.
  • Truvestments Capital's ten largest holdings make up 27% of its $144M portfolio in Q4 2019.
  • Truvestments Capital opened 1 new position and closed 564 in Q4 2019.
  • Truvestments Capital's portfolio value fell 6% quarter-over-quarter to $144M.

Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.